The state of the clerkship: a survey of emergency medicine clerkship directors.

Linda Kruus , David E. Manthey , David A. Wald , Jeffrey Barrett
Academic Emergency Medicine 14 ( 7) 629 -634

48
2007
Postpartum cerebral venous sinus thrombosis after dural puncture and epidural blood patch.

Jeffrey Barrett , Eric Alves
Journal of Emergency Medicine 28 ( 3) 341 -342

19
2005
Traumatic, pericardio-diaphragmatic rupture: an extremely rare cause of pericarditis.

Jeffrey Barrett , Wayne Satz
Journal of Emergency Medicine 30 ( 2) 141 -145

18
2006
Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study.

Jeffrey Barrett , Christopher Assaid , Michael Fossler , Donna Cox
Thrombosis and Haemostasis 87 ( 5) 817 -823

88
2002
Practical Considerations for Dose Selection in Pediatric Patients to Ensure Target Exposure Requirements

April M. Barbour , Michael J. Fossler , Jeffrey Barrett
The AAPS Journal 16 ( 4) 749 -755

8
2014
Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers

Howard E. Greenberg , Paul Wissel , Jeffrey Barrett , Aaron Barchowsky
The Journal of Clinical Pharmacology 40 ( 5) 496 -507

24
2000
Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats.

Kathleen Gerbeth , Jan Hüsch , Jürgen Meins , Antonietta Rossi
Planta Medica 78 ( 18) 1932 -1938

5
2012
The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage

RichardL. Wahl , Jeffrey Barrett , Onelio Geatti , Monica Liebert
Cancer Immunology, Immunotherapy 26 ( 3) 187 -201

51
1988
Fluconazole Population Pharmacokinetics and Dosing for Prevention and Treatment of Invasive Candidiasis in Children Supported with Extracorporeal Membrane Oxygenation

Kevin M. Watt , Daniel Gonzalez , Daniel K. Benjamin , Kim L. R. Brouwer
Antimicrobial Agents and Chemotherapy 59 ( 7) 3935 -3943

23
2015
Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group

Patrick A. Thompson , Manish Gupta , Gary L. Rosner , Alexander Yu
Cancer Chemotherapy and Pharmacology 62 ( 6) 1027 -1037

18
2008
Enhancing the Utility of Systems Pharmacology Modeling in Pharmaceutical R&D: Lessons from the Development of a PCSK9 Inhibitor Model

Karim Azer , Jeffrey E Ming , Tu Nguyen , Alex Koszycki
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 42 S67 -S68

2015
Trial outcome simulations evaluating" Pick the winner strategy" to support new candidate screen myeloid leukemia

Michael Fossler , Todd Alonzo , Joseph Beyene , Alan Gamis
Journal of Clinical Pharmacology 48 ( 9) 1124 -1124

1
2008
An ePKPD model for sodium nitroprusside in adolescents

Salma Bahnasawy , Hesham Al-Sallami , Jeffrey Barrett , Stephen Duffull
PAGANZ 2019 Abstracts 35 -35

2019
Pharmacometrics in pediatrics

Jeffrey Barrett
Applied pharmacometrics 83 -108

9
2014
Can innovative trial designs in orphan diseases drive advancement of treatments for common neurological diseases?

Diane Stephenson , Cecile Ollivier , Roberta Brinton , Jeffrey Barrett
Clinical Pharmacology & Therapeutics 111 ( 4) 799 -806

5
2022
Human bites

Jeffrey Barrett , Don R Revis

4
2015